The container-based structures company SG Blocks Inc. says it has entered the US test lab market for the novel coronavirus and other diseases through a joint venture with Clarity Diagnostics.

Clarity and SG Blocks will work together under the name Clarity Modular Lab Solutions to craft federal CLIA-certified laboratories. In May, SG Blocks announced a deal with OSANG Healthcare Co. Ltd. to distribute its COVID-19 test.

SG Blocks and Clarity said their venture will "accelerate speed of deployment and redeployment into underserved hot spots of labs certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) that require high connectivity." The joint venture, the companies said in a statement, "is designed to provide fast, accurate and reliable point of care testing that has been elusive for the poor and working classes."

Want to continue reading?
Become a Free ALM Digital Reader.

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Mike Scarcella

Mike Scarcella is a senior editor in Washington on ALM Media's regulatory desk. Contact him at [email protected]. On Twitter: @MikeScarcella. Mike works on a slate of newsletters: Supreme Court Brief | Higher Law | Compliance Hot Spots | Labor of Law.